http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_825ab47d2519be39a82be7b88b01592d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Stroobant |
| name | Vincent Stroobant |
| given-name | Vincent |
| organization-name | From the *Ludwig Institute for Cancer Research, Université Catholique de Louvain 74.59, B-1200 Brussels, Belgium; the ‡Laboratory of Physiology, Medical School, Free University of Brussels, B-1070 Brussels, Belgium; and §Erasmus University Rotterdam, Department of Surgical Oncology, University Hospital Rotterdam, Daniel den Hoed Cancer Center, 3075 EA Rotterdam, The Netherlands Ludwig Institute for Cancer Research Brussels Branch Brussels Belgium; WELBIO and de Duve Institute Université catholique de Louvain Brussels Belgium Ludwig Institute for Cancer Research and Cellular Genetics Unit, Université de Louvain, B-1200 Brussels, Belgium.; Laboratoire de Chirurgie Expérimentale, Université de Liège, B-4000 Liège, Belgium. *Ludwig Institute for Cancer Research, Brussels B-1200, Belgium;; †Walloon Excellence in Life Sciences and Biotechnology, Brussels B-1200, Belgium;; ‡de Duve Institute, Université catholique de Louvain, Brussels B-1200, Belgium; Ludwig Institute for Cancer Research Université Catholique de Louvain Brussels Belgium Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98195, USA.; Department of Immunology, University of Washington, Seattle, WA 98195, USA.; Ludwig Institute for Cancer Research, Brussels Branch, B-1200 Brussels, Belgium.; Cellular Genetics Unit, Institute of Cellular Pathology, Université Catholique de Louvain, B-1200 Brussels, Belgium. Butenandt Institute for Physiological Chemistry, Ludwig-Maximilians University, D-81377 Munich, Germany, Cell Biology, University of Kaiserslautern, D-67663 Kaiserslautern, Germany, and Ludwig Institute for Cancer Research and Cellular Genetics Unit, Université Catholique de Louvain, B-1200 Brussels, Belgium Service de Spectrométrie de Masse, Université Catholique de Louvain, Louvain-la-Neuve, Belgium Ludwig Institute for Cancer Research, Avenue Hippocrate 75, 1200 Brussels, Belgium *Ludwig Institute for Cancer Research, Brussels Branch, B-1200 Brussels, Belgium;; †de Duve Institute, B-1200 Brussels, Belgium;; ‡Université catholique de Louvain, B-1200 Brussels, Belgium;; §Walloon Excellence in Life Sciences and Biotechnology, B-1200 Brussels, Belgium; Ludwig Institute for Cancer Research, Brussels Branch and de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium; and Ludwig Institute for Cancer Research, Brussels B-1200, Belgium; de Duve Institute, UCLouvain, Brussels B-1200, Belgium 1Ludwig Institute for Cancer Research, Brussels, Belgium.; 2de Duve Institute, Université catholique de Louvain, Brussels, Belgium. *Ludwig Institute for Cancer Research, Brussels Branch and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium; and Brussels Branch of the Ludwig Institute, Brussels, Belgium *Ludwig Institute for Cancer Research, Brussels, Belgium;; †de Duve Institute, Université Catholique de Louvain, Brussels, Belgium;; ‡Walloon Excellence in Lifesciences and Biotechnology, Brussels, Belgium; and †Ludwig Institute for Cancer Research, Brussels, Belgium; and Ludwig Institute for Cancer Research, 1200 Brussels, Belgium Ludwig Cancer Research, Brussels Branch Brussels Belgium Authors' Affiliations: 1Ludwig Institute for Cancer Research Brussels and WELBIO; 2de Duve Institute; Departments of 3Gynecology and 4Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain; 5Laboratory of Molecular and Cellular Therapy, Department of Immunology-Physiology, Medical School of the Vrije Universiteit Brussel, Brussels; and 6Department of Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium; Authors' Affiliations: 1Ludwig Institute for Cancer Research Brussels and WELBIO; 2de Duve Institute; Departments of 3Gynecology and 4Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain; 5Laboratory of Molecular and Cellular Therapy, Department of Immunology-Physiology, Medical School of the Vrije Universiteit Brussel, Brussels; and 6Department of Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium *Ludwig Institute for Cancer Research, Brussels Branch and Cellular Genetics Unit, Université de Louvain, Brussels, Belgium; *Ludwig Institute for Cancer Research, Brussels, Belgium; Ludwig Institute for Cancer Research, de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium; Ludwig Institute for Cancer Research, 1200 Brussels, Belgium;; de Duve Institute, Université catholique de Louvain, 1200 Brussels, Belgium; Ludwig Institute for Cancer Research, Brussels Branch, 1200 Brussels, Belgium;; de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium; Ludwig Institute for Cancer Research, Brussels Branch, and Unité de Génétique Cellulaire, Université Catholique de Louvain, Brussels, Belgium Ludwig Institute for Cancer Research, Université Catholique de Louvain, 74 Avenue Hippocrate, 1200 Brussels, Belgium Ludwig Institute for Cancer Research, Brussels Branch, and de Duve Institute, Catholic University of Louvain, Brussels, Belgium *Ludwig Institute for Cancer Research, Brussels B-1200, Belgium;; ‡de Duve Institute, Université Catholique de Louvain, Brussels B-1200, Belgium; Authors' Affiliations: 1de Duve Institute, Université Catholique de Louvain and 2Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium; Authors' Affiliations: 1de Duve Institute, Université Catholique de Louvain and 2Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium 1Ludwig Institute for Cancer Research, Brussels, Belgium.; 2de Duve Institute, UCLouvain, Brussels, Belgium. *Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium;; †Waloon Excellence in Life Sciences and Biotechnology, B-1200 Brussels, Belgium;; ‡de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium; *Ludwig Institute for Cancer Research and Cellular Genetics Unit, Université de Louvain, Brussels, Belgium; Ludwig Institute for Cancer Research, Brussels Branch, and de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium Ludwig Institute for Cancer Research, Brussels, Belgium; de Duve Institute, UCLouvain, Brussels, Belgium Ludwig Institute for Cancer Research, Brussels Branch, and de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium; and *Ludwig Institute for Cancer Research, Brussels Branch, and Cellular Genetics Unit, Université Catholique de Louvain (UCL), Brussels, Belgium; and Cellular Genetics Unit, Institute of Cellular Pathology, Université Catholique de Louvain, B-1200 Brussels, Belgium; Ludwig Institute for Cancer Research, Brussels Branch, B-1200 Brussels, Belgium Brussels Branch, Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium Ludwig Institute for Cancer Research, Brussels Branch, B-1200 Brussels, Belgium; aLudwig Institute for Cancer Research and Cellular Genetics Unit, Université Catholique de Louvain, Brussels 1200, Belgium |
Incoming Links
Total number of triples: 135.